Press Releases from DelveInsight Business Research (5627 total)
Adult Growth Hormone Deficiency Market Forecast 2032: FDA, EMA, PDMA Approvals, …
(Albany, USA) DelveInsight's "Adult Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adult Growth Hormone Deficiency, historical and…
Pyelonephritis Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pyelonephritis pipeline constitutes 20+ key companies continuously working towards developing 20+ Pyelonephritis treatment therapies, analysis…
Diabetic Gastroparesis Market Forecast 2032: FDA Approval, Epidemiology, Therapi …
(Albany, USA) DelveInsight's "Diabetic Gastroparesis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Diabetic Gastroparesis, historical and forecasted epidemiology as well…
Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Drugs Pipeline …
(Las Vegas, Nevada, United States) "Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development…
HDAC Inhibitor Pipeline Assessment 2024 (Updated): FDA, EMA, PDMA Approvals, Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment…
Fabry Disease Market is expected to grow at a CAGR of about ~6% 2032, estimates …
(Albany, USA) DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fabry Disease, historical and forecasted epidemiology as well…
Secondary Hyperparathyroidism Market Forecast 2032: Clinical Trials, FDA Approva …
(New York, USA) DelveInsight's "Secondary Hyperparathyroidism Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Secondary Hyperparathyroidism, historical and forecasted epidemiology as…
Atypical Hemolytic Uremic Syndrome Market Forecast 2032: Epidemiology, FDA Appro …
(Albany, USA) DelveInsight's "Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atypical Hemolytic Uremic Syndrome, historical and…
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Assessment 2024 Updates: …
(New York, United States) As per DelveInsight's assessment, globally, EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline constitutes 30+ key companies continuously working…
Spinal Muscular Atrophy Pipeline Assessment 2024 (Updated), Clinical Trials, Tre …
Spinal Muscular Atrophy pipeline constitutes 18+ key companies continuously working towards developing 20+ Spinal Muscular Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of…
Human Immunodeficiency Virus Type 1 Market Forecast 2032: Clinical Trials, Epide …
(New York, USA) DelveInsight's "Human Immunodeficiency Virus Type 1 Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Human Immunodeficiency Virus Type…
HPK1 Inhibitor Market Poised for Growth by 2032, Projects DelveInsight| BeiGene, …
(Albany, USA) DelveInsight's "HPK1 Inhibitor Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of HPK1 Inhibitor, historical and forecasted epidemiology as well…
The Global Powered Surgical Instruments Market to Register Growth at a Stunning …
(Albany, USA) As per DelveInsight analysis, the Powered Surgical Instruments market is growing positively due to the factors such as an increase in geriatric population,…
The Global Glaucoma Drainage Devices Market to Register Growth at a Stunning CAG …
The glaucoma drainage devices market is anticipated to boost owing to the rising prevalence of glaucoma diseases, the rising geriatric population susceptible to glaucoma, the…
Diffuse Large B-cell Lymphoma Pipeline Assessment 2024: Clinical Trials, FDA App …
As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Diffuse Large B-cell Lymphoma therapeutics…
Esophageal Squamous Cell Carcinoma Pipeline Assessment 2024: Clinical Trials, FD …
(Albany, USA) DelveInsight's, "Esophageal Squamous Cell Carcinoma Pipeline Insight" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Esophageal Squamous Cell…
Metastatic Renal Cell Carcinoma Pipeline Assessment 2024: Clinical Trials, FDA A …
(Albany, USA) DelveInsight's, "Metastatic Renal Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Metastatic Renal Cell…
Mesothelioma Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies …
(Albany, USA) DelveInsight's, "Mesothelioma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Mesothelioma pipeline landscape. It covers…
Oncolytic Virus Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therap …
DelveInsight's, "Oncolytic Virus Competitive Landscape" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers…
Microbiome Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies, …
DelveInsight's, "Microbiome Competitive Landscape 2024" report provides comprehensive insights about 130+ Microbiome companies and 180+ drugs in Microbiome Competitive landscape. It covers the Microbiome therapeutics…
Anti-CD19 Antibody Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Ap …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anti-CD19 Antibody pipeline constitutes key companies continuously working towards developing Anti-CD19 Antibody treatment therapies,…
BK virus infections Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, BK virus infections pipeline constitutes 7+ key companies continuously working towards developing 8+ BK…
Pancreatic Ductal Adenocarcinoma Pipeline Analysis, 2024 Updates | Latest FDA, E …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pancreatic Ductal Adenocarcinoma pipeline constitutes 80+ key companies continuously working towards developing 80+ Pancreatic…
Conductive Hearing Loss Market to Exhibit Rapid Growth Rate During the Forecast …
DelveInsight's "Conductive Hearing Loss Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Conductive Hearing Loss, historical and forecasted epidemiology as…
Deep Vein Thrombosis Market Report 2032: Epidemiology Data, Pipeline Therapies, …
DelveInsight's "Deep Vein Thrombosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Deep Vein Thrombosis, historical and forecasted epidemiology as…
Extensive Stage Small Cell Lung Cancer Pipeline Assessment 2024: Clinical Trials …
DelveInsight's, "Extensive Stage Small Cell Lung Cancer Pipeline Insight" report provides comprehensive insights about 40+ Extensive Stage Small Cell Lung Cancer companies and 40+ pipeline…
Gene Therapy In CNS Disorder Market Poised for Growth by 2032, Projects DelveIns …
DelveInsight's "Gene Therapy In CNS Disorder Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Gene Therapy In CNS…
Gastroesophageal Junction Adenocarcinoma Market Poised for Growth by 2032, Proje …
DelveInsight's "Gastroesophageal Junction Adenocarcinoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Gastroesophageal Junction Adenocarcinoma, historical and forecasted…
Gastritis Market is expected to show Robust growth by 2032, analyzes DelveInsigh …
DelveInsight's "Gastritis Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Gastritis, historical and forecasted epidemiology as well as the…
Cone Rod Dystrophy Market is expected to show Robust growth by 2032, analyzes De …
DelveInsight's "Cone Rod Dystrophy Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Cone Rod Dystrophy, historical and forecasted…
Beta Thalassemia Market is expected to show Robust growth by 2032 | DelveInsight
(Albany, USA) DelveInsight's 'Beta Thalassemia Market Insights, Epidemiology, and Market Forecast-2032' report deliver an in-depth understanding of Beta Thalassemia, historical and forecasted epidemiology as well…
Renal Cancer Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies …
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape.…
Diffuse Intrinsic Pontine Glioma Pipeline Assessment 2024: Clinical Trials, FDA …
(Albany, USA) DelveInsight's, "Diffuse Intrinsic Pontine Glioma Pipeline Insight" report provides comprehensive insights about 25+ Diffuse Intrinsic Pontine Glioma companies and 25+ pipeline drugs in…
Ewing Sarcoma Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapie …
(Albany, USA) DelveInsight's, "Ewing Sarcoma Pipeline Insights" report provides comprehensive insights about 25+ Ewing Sarcoma companies and 25+ pipeline drugs in the Ewing Sarcoma pipeline…
Acute Lymphocytic Leukemia Pipeline Assessment 2024: Clinical Trials, FDA Approv …
(Albany, USA) DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia pipeline…
Non-Small Cell Lung Cancer Pipeline Assessment 2024: Clinical Trials, FDA Approv …
DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ Non-Small Cell Lung Cancer Companies and 150+ pipeline drugs in the Non-Small-Cell…
Non-Hodgkin Lymphoma Pipeline Analysis 2024: FDA Approvals, Clinical Trials, The …
DelveInsight's, "Non-Hodgkin Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 200+ Non-Hodgkin Lymphoma companies and 220+ pipeline drugs in the Non-Hodgkin Lymphoma pipeline landscape.…
Migraine Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mech …
(Albany, United States) As per DelveInsight's assessment, globally, Migraine pipeline constitutes 30+ key companies continuously working towards developing 30+ Migraine treatment therapies, analysis of Clinical…
Hyperphosphatemia Market Report 2032: Epidemiology Data, Pipeline Therapies, Lat …
DelveInsight's "Hyperphosphatemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hyperphosphatemia, historical and forecasted epidemiology as well as the Hyperphosphatemia…
Homocystinuria Market is Expected to Expand at a Healthy Growth Rate During the …
DelveInsight's "Homocystinuria Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Homocystinuria, historical and forecasted epidemiology as well as the Homocystinuria…
Marginal Zone Lymphoma Pipeline Review | Latest FDA, EMA, and PMDA Approvals, No …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Marginal Zone Lymphoma pipeline constitutes 50+ key companies continuously working towards developing 50+ Marginal…
Major Depressive Disorder Pipeline and Clinical Trials Assessment, 2024 Updates: …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Major Depressive Disorder pipeline constitutes 7+ key companies continuously working towards developing 8+ Major…
Diabetic Macular Edema Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emergi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Macular Edema pipeline constitutes key companies continuously working towards developing Diabetic Macular Edema…
Postoperative Pain Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Postoperative Pain pipeline constitutes 45+ key companies continuously working towards developing 50+ Postoperative Pain…
Duchenne Muscular Dystrophy Pipeline Assessment 2024: Clinical Trials, FDA Appro …
(Albany, USA) DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024," report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy…
Biliary Tract Cancers Pipeline Assessment 2024: Clinical Trials, FDA Approvals, …
DelveInsight's, "Biliary Tract Cancers Pipeline Insight, 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers pipeline landscape.…
Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Assessment 2024: Clinica …
(Albany, USA) DelveInsight's, "Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024," report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Wet Age-Related…
PCSK9 Inhibitor Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therap …
(Albany, United States) As per DelveInsight's assessment, globally, the PCSK9 Inhibitor Pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitor Pipeline treatment…
Hyperphosphatemia Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, the Hyperphosphatemia Pipeline constitutes 15+ key companies continuously working towards developing 15+ Hyperphosphatemia Pipeline treatment therapies, analysis…
Androgenetic Alopecia Market and Epidemiology 2032: Treatment Market, Therapies, …
The Androgenetic Alopecia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Androgenetic…
